new glp-1 drugs in development Market Size to Hit USD 132.79 Bn by 2035 GLP-1 analogs, new trend in

The reality of the Ozempic Rebound underscores the importance of addressing the underlying causes that lead to weight gain to begin with

DeGruttola AK, Low D, Mizoguchi A, Mizoguchi E

If you reach 8 to 12mg retatrutide and your results are inferior to what tirzepatide produced, switching back is a reasonable option

It reduces appetite by targeting brain areas that control hunger, slows gastric emptying to extend feelings of fullness, and improves insulin sensitivity

Novel glucagon-like peptide-1 analogue exhibits potency-driven G-protein biased agonism with promising effects on diabetes and diabetic dry eye syndrome

Ask your provider to run a basic metabolic panel and check B12, Vitamin D, and iron levels so you can address any existing deficiencies with targeted supplementation